Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

20,769 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Progression-free and overall survival in ovarian cancer patients treated with CVac, a mucin 1 dendritic cell therapy in a randomized phase 2 trial.
Gray HJ, Benigno B, Berek J, Chang J, Mason J, Mileshkin L, Mitchell P, Moradi M, Recio FO, Michener CM, Secord AA, Tchabo NE, Chan JK, Young J, Kohrt H, Gargosky SE, Goh JC. Gray HJ, et al. Among authors: chang j. J Immunother Cancer. 2016 Jun 21;4:34. doi: 10.1186/s40425-016-0137-x. eCollection 2016. J Immunother Cancer. 2016. PMID: 27330807 Free PMC article.
Platinum-Taxol non-cross resistance in epithelial ovarian cancer.
Gore ME, Preston N, A'Hern RP, Hill C, Mitchell P, Chang J, Nicolson M. Gore ME, et al. Among authors: chang j. Br J Cancer. 1995 Jun;71(6):1308-10. doi: 10.1038/bjc.1995.253. Br J Cancer. 1995. PMID: 7779729 Free PMC article. Clinical Trial.
A phase II randomized trial evaluating gefitinib intercalated with pemetrexed/platinum chemotherapy or pemetrexed/platinum chemotherapy alone in unselected patients with advanced non-squamous non-small cell lung cancer.
Yu H, Zhang J, Wu X, Luo Z, Wang H, Sun S, Peng W, Qiao J, Feng Y, Wang J, Chang J. Yu H, et al. Among authors: chang j. Cancer Biol Ther. 2014 Jul;15(7):832-9. doi: 10.4161/cbt.28874. Epub 2014 Apr 22. Cancer Biol Ther. 2014. PMID: 24755888 Free PMC article. Clinical Trial.
A multi-center phase II study and biomarker analysis of combined cetuximab and modified FOLFIRI as second-line treatment in patients with metastatic gastric cancer.
Liu X, Guo W, Zhang W, Yin J, Zhang J, Zhu X, Liu T, Chen Z, Wang B, Chang J, Lv F, Hong X, Wang H, Wang J, Zhao X, Wu X, Li J. Liu X, et al. Among authors: chang j. BMC Cancer. 2017 Mar 14;17(1):188. doi: 10.1186/s12885-017-3174-z. BMC Cancer. 2017. PMID: 28288572 Free PMC article. Clinical Trial.
Weekly albumin-bound paclitaxel/cisplatin versus gemcitabine/cisplatin as first-line therapy for patients with advanced non-small-cell lung cancer: A phase II open-label clinical study.
Qin S, Yu H, Wu X, Luo Z, Wang H, Sun S, Huang M, Jin J, Tao Z, Qiao J, Feng Y, Wang J, Chang J. Qin S, et al. Among authors: chang j. Chin J Cancer Res. 2019 Apr;31(2):339-348. doi: 10.21147/j.issn.1000-9604.2019.02.08. Chin J Cancer Res. 2019. PMID: 31156304 Free PMC article.
[A randomized, controlled, multicenter clinical trial comparing pemetrexed/cisplatin and gemcitabine/cisplatin as first-line treatment for advanced nonsquamous non-small cell lung cancer].
Huang Y, Liu Y, Zhou J, Xu N, Li B, Wu G, Fang J, Li K, Liu X, Liu W, Lu Y, Wang M, Liu W, Liang H, Zhang Y, Huang C, Wang S, Wang Y, Yu S, Chang J, Wang Z, Hu Z, Zhang L. Huang Y, et al. Among authors: chang j. Zhongguo Fei Ai Za Zhi. 2012 Oct;15(10):576-82. doi: 10.3779/j.issn.1009-3419.2012.10.03. Zhongguo Fei Ai Za Zhi. 2012. PMID: 23075681 Free PMC article. Clinical Trial. Chinese.
20,769 results
You have reached the last available page of results. Please see the User Guide for more information.